ATE189818T1 - Papillomavirusuntereinheit-impfstoff - Google Patents

Papillomavirusuntereinheit-impfstoff

Info

Publication number
ATE189818T1
ATE189818T1 AT92900509T AT92900509T ATE189818T1 AT E189818 T1 ATE189818 T1 AT E189818T1 AT 92900509 T AT92900509 T AT 92900509T AT 92900509 T AT92900509 T AT 92900509T AT E189818 T1 ATE189818 T1 AT E189818T1
Authority
AT
Austria
Prior art keywords
vaccine
papillomavirus
sequence
drahyni
subunity
Prior art date
Application number
AT92900509T
Other languages
English (en)
Inventor
Robert Tindle
Germain Fermando
Ian Frazer
Original Assignee
Univ Queensland
Csl Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Queensland, Csl Ltd filed Critical Univ Queensland
Application granted granted Critical
Publication of ATE189818T1 publication Critical patent/ATE189818T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/20011—Papillomaviridae
    • C12N2710/20022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
AT92900509T 1990-12-12 1991-12-12 Papillomavirusuntereinheit-impfstoff ATE189818T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AUPK387690 1990-12-12
PCT/AU1991/000575 WO1992010513A1 (en) 1990-12-12 1991-12-12 Subunit papillomavirus vaccine and peptides for use therein

Publications (1)

Publication Number Publication Date
ATE189818T1 true ATE189818T1 (de) 2000-03-15

Family

ID=3775135

Family Applications (1)

Application Number Title Priority Date Filing Date
AT92900509T ATE189818T1 (de) 1990-12-12 1991-12-12 Papillomavirusuntereinheit-impfstoff

Country Status (7)

Country Link
EP (1) EP0561885B1 (de)
JP (1) JPH06503559A (de)
KR (1) KR100252371B1 (de)
AT (1) ATE189818T1 (de)
CA (1) CA2097916C (de)
DE (1) DE69131992T2 (de)
WO (1) WO1992010513A1 (de)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8062642B1 (en) 1993-03-09 2011-11-22 University Of Rochester Production of papillomavirus capsid protein and virus-like particles
US6153201A (en) * 1993-03-09 2000-11-28 University Of Rochester Oral immunization with papillomavirus virus-like particles
AUPN015794A0 (en) 1994-12-20 1995-01-19 Csl Limited Variants of human papilloma virus antigens
AUPN443995A0 (en) * 1995-07-27 1995-08-17 Csl Limited Papillomavirus polyprotein
US6183746B1 (en) 1997-10-09 2001-02-06 Zycos Inc. Immunogenic peptides from the HPV E7 protein
DE19819476C1 (de) * 1998-04-30 2000-01-05 Deutsches Krebsforsch Polypeptid mit immunogenen Eigenschaften und veränderten biologischen Funktionen eines Proteins
DE19925199A1 (de) * 1999-06-01 2000-12-07 Medigene Ag Zytotoxische T-Zellepitope des Papillomavirus L1-Proteins und ihre Verwendung in Diagnostik und Therapie
DE19925235A1 (de) 1999-06-01 2000-12-07 Medigene Ag Zytotoxische T-Zellepitope des Papillomavirus L1-Proteins und ihre Verwendung in Diagnostik und Therapie
CA2431500C (en) 2000-12-08 2016-06-07 Sjoerd Hendrikus Van Der Burg Long peptides of 22-45 amino acid residues that induce and/or enhance antigen specific immune responses
EP1288292A1 (de) * 2001-08-31 2003-03-05 Leids Universitair Medisch Centrum Lange Peptiden die 22-40 Aminosäuren enthalten und die eine immunspezifische Immunantwort induzieren
WO2002100889A1 (fr) * 2001-06-08 2002-12-19 Kirin Beer Kabushiki Kaisha Nouvel epitope de l'antigene e7 du papillomavirus humain et lymphocytes t cd4 positifs actives par l'epitope
CA2523032A1 (en) 2005-10-07 2007-04-07 Immunovaccine Technologies Inc. Vaccines for cancer therapy
CN105063064B (zh) * 2006-07-28 2024-09-24 宾夕法尼亚大学托管会 改进的疫苗及其使用方法
CU23674A1 (es) 2007-07-31 2011-05-27 Ct Ingenieria Genetica Biotech Péptidos penetradores a células fusionados a una biomolécula con acción terapéutica
ES2588705T3 (es) 2007-09-27 2016-11-04 Immunovaccine Technologies Inc. Uso de liposomas en un vehículo que comprende una fase hidrófoba continua para la entrega de polinucleótidos in vivo
CA2723918C (en) 2008-06-05 2018-01-09 Immunovaccine Technologies Inc. Compositions comprising liposomes, an antigen, a polynucleotide and a carrier comprising a continuous phase of a hydrophobic substance
IN2014CN02581A (de) 2011-10-06 2015-08-07 Immunovaccine Technologies Inc

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2641081A1 (de) * 1988-12-23 1990-06-29 Medgenix Group
AU650868B2 (en) * 1990-03-20 1994-07-07 Behringwerke Aktiengesellschaft Seroreactive epitopes of human papillomavirus (HPV) 16 proteins
PT523391E (pt) * 1991-07-13 2003-08-29 Dade Behring Marburg Gmbh Utilizacao dos peptidos derivados dos genes hpv-16 e6 e e7 para fins de diagnostico

Also Published As

Publication number Publication date
DE69131992T2 (de) 2000-06-29
EP0561885A1 (de) 1993-09-29
CA2097916C (en) 2001-08-21
JPH06503559A (ja) 1994-04-21
KR100252371B1 (ko) 2000-05-01
WO1992010513A1 (en) 1992-06-25
CA2097916A1 (en) 1992-06-13
EP0561885A4 (en) 1994-09-21
EP0561885B1 (de) 2000-02-16
DE69131992D1 (de) 2000-03-23

Similar Documents

Publication Publication Date Title
ATE189818T1 (de) Papillomavirusuntereinheit-impfstoff
PH12022552164A1 (en) Designer peptides and proteins for the detection, prevention and treatment of coronavirus disease, 2019 (covid-19)
DK0593754T3 (da) Peptider fra humant papillomavirus til anvendelse i præparater til induktion af humant T-celle respons
BR9814487A (pt) "vacina"
CA2074153A1 (en) Seroreactive regions on hpv 16 proteins e1 and e2
MA24638A1 (fr) Vaccin
DE69334192D1 (de) Papillomavirus vakzine
MXPA02005639A (es) Induccion de respuestas celulares iinmunologicas al virus de papiloma humano y utilizacion de composiciones de peptidos y acidos nucleico.
DE59608274D1 (de) Cyclosporin-derivate mit anti-hiv-wirkung
DE69206631D1 (de) Impfstoff gegen das Fortpflanzungs- und Atmungssyndrom bei Schweinen (PRRS) und Diagnose.
PT101052A (pt) Proteinas hibridas uteis na preparacao de vacinas
CA2042236A1 (en) Seroreactive epitopes on proteins of human papillomavirus (hpv) 18
SE9903031D0 (sv) Peptide mixture and vaccine against a chronic viral infection
EP0762895A4 (de) Synthetischer impfstoff zum schutz gegen infektionen mit dem menschlichen immunschwächevirus
ATE193974T1 (de) Chlamydia impfstoffen
RU2002111554A (ru) Вакцина
AUPN712795A0 (en) Recombinant vaccines
NZ295056A (en) Hepatitis virus e strain, recombinant proteins thereof, use in diagnostic methods and vaccines
WO1999024466A3 (en) Multi-mer peptides derived from hepatitis c virus envelope proteins for diagnostic use and vaccination purposes
DE69433057D1 (de) Peptide zur verwendung bei der impfung und induktion neutralisierender antikörper gegen das menschliche immunschwäche-virus
Ivanoff et al. Human immunodeficiency virus antigen.
WO2002051865A3 (fr) Antigenes proteiques inducteurs d'anticorps neutralisant le virus vih
WO2024186803A3 (en) Nucleocapsid antigen immunotherapy for covid-19 fusion proteins and methods of use
EP0808846A3 (de) Peptide, die mit Antikörpern reagieren, die den Fortschritt der HIV-Erkrankung markieren
TH4070A (th) ลำดับ dna ที่มีรหัสของเซอร์เฟสแอนติเจนโปรตีน p31 ที่ดัดแปลงของไวรัสเฮพพาทิทิส บี

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
EELA Cancelled due to lapse of time